ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.130
$0.180 (5.44%)
Day Range
$3.030 - $3.400
52 Week Range
$0.560 - $5.240
Volume
476.82K
Avg Volume (10D)
545.22K
Market Cap
$494.80M
Price Chart
Market Statistics
Open$3.340
Previous Close$3.310
Day High$3.400
Day Low$3.030
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap494.80M
Shares Outstanding158.08M
Price to Book5.54
Trading Activity
Volume476.82K
Value Traded1.54M
Bid$3.010 × 270
Ask$3.170 × 1,556
Performance
1 Day-5.44%
5 Day-7.40%
13 Week-33.55%
52 Week314.57%
YTD-33.55%
Technical Indicators
RSI (14)49.05
50-Day SMA$3.293
200-Day SMA$2.744
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
